Continuous manufacturing applicants saw quicker approvals, higher revenue than batch applicants
Regulatory NewsJeff Craven
Chemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsProduct LifecycleRegulatory NewsJeff CravenChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsProduct Lifecycle